Beatriz Esteban-Cartelle
Overview
Explore the profile of Beatriz Esteban-Cartelle including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
31
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Esteban-Cartelle B, Serrano D, Perez Menendez-Conde C, Vicente-Oliveros N, Alvarez-Diaz A, Fortun Abete J, et al.
Microbiol Spectr
. 2023 Dec;
12(1):e0206423.
PMID: 38088799
Although outpatient parenteral antibiotic therapy can be a good approach to treating infections, a lack of data regarding antibiotic stability in portable elastomeric infusion devices restricts its safe and effective...
2.
Velez-Diaz-Pallares M, Esteban-Cartelle B, Gramage-Caro T, Montero-Llorente B, Parro-Martin M, Rodriguez-Sagrado M, et al.
Rev Esp Salud Publica
. 2023 Jun;
97.
PMID: 37334559
Objective: HIV Clinical Guidelines have positioned integrase inhibitors recently as first-line treatment. However, two of these drugs have also been associated with adverse side effects on the central nervous system,...
3.
Esteban-Cartelle B, Vicente-Oliveros N, Perez Menendez-Conde C, Serrano D, Martin-Davila P, Fortun-Abete J, et al.
Am J Health Syst Pharm
. 2022 May;
79(16):1355-1368.
PMID: 35511829
Purpose: Although outpatient parenteral antibiotic therapy (OPAT) can be a good approach to treatment of infections, a lack of data regarding antibiotic stability in portable elastomeric infusion devices restricts its...
4.
Velez-Diaz-Pallares M, Esteban-Cartelle B, Montero-Llorente B, Gramage-Caro T, Rodriguez-Sagrado M, Bermejo-Vicedo T
Enferm Infecc Microbiol Clin (Engl Ed)
. 2019 Nov;
38(5):212-218.
PMID: 31753469
Introduction: The prescription of antiretroviral treatment (ART) that contains pharmacokinetic enhancers such as ritonavir and cobicistat is frequent. The objective of this stdy was to analyze the potential interactions of...
5.
Lopez-Huertas M, Palladino C, Garrido-Arquero M, Esteban-Cartelle B, Sanchez-Carrillo M, Martinez-Roman P, et al.
Sci Rep
. 2019 Apr;
9(1):5606.
PMID: 30944340
In HIV-1/HCV-coinfected patients, chronic HCV infection leads to an increased T-lymphocyte immune activation compared to HIV-monoinfected patients, thereby likely contributing to increase HIV-1 reservoir that is the major barrier for...
6.
Palladino C, Esteban-Cartelle B, Mate-Cano I, Sanchez-Carrillo M, Resino S, Briz V
Enferm Infecc Microbiol Clin (Engl Ed)
. 2017 May;
36(5):262-267.
PMID: 28521955
Resistance-associated substitutions (RASs) to the new HCV NS5A inhibitor elbasvir may limit its efficacy and lead to virological failure in HCV-GT1a-infected patients. There are no data outside clinical trials evaluating...